Vacinas de MRNA e resposta imunológica: mecanismos de ação e eficácia imunológica

Messenger RNA (MRNA)-based vaccines represent an unprecedented technological revolution in the history of immunology and modern biotechnology, becoming firmly established during the global health crisis triggered by the COVID-19 pandemic. Unlike traditional vaccines, which use attenuated or inactivated pathogens, this innovative platform employs synthetic nucleotide sequences encapsulated in lipid nanoparticles to instruct the host cell machinery to synthesize specific antigens endogenously. This study aimed to conduct an in-depth analysis of the molecular and cellular mechanisms of action of mRNA vaccines, as well as to evaluate their overall immunological efficacy, safety profile, and future therapeutic implications. To this end, a descriptive and analytical integrative literature review was conducted, based on a systematic search of internationally recognized scientific databases, including PubMed, SciELO, Web of Science, and Google Scholar, covering publications from 2019 to 2024. The findings synthesized from the literature demonstrate that MRNA formulations trigger a vigorous and coordinated activation of both innate and adaptive immunity. The internalization of lipid nanoparticles by dendritic cells and macrophages activates pattern recognition receptors (PRRs), inducing the secretion of essential inflammatory cytokines and chemokines. Subsequently, antigen presentation via major histocompatibility complex (MHC) molecules stimulates the activation of helper T lymphocytes (CD4⁺) and cytotoxic T lymphocytes (CD8⁺), alongside the maturation of plasma cells that produce high-affinity neutralizing antibodies and the robust generation of long-lived memory T and B lymphocytes. Documented clinical efficacy exceeded 90% against severe symptomatic disease, highlighting the platform's advantages in terms of structural flexibility and rapid adaptability to the continuous emergence of new viral variants. It is concluded that MRNA vaccines extend beyond the scope of COVID-19 prophylaxis, ushering in a new therapeutic era with potential applications in the management of malignant neoplasms, autoimmune diseases, and chronic viral infections.

Authors

Publication Details

Journal
Revista fisio&terapia.
Published
2026-11-12
DOI
https://doi.org/10.69849/2k57xg49
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Vacinas de MRNA e resposta imunológica: mecanismos de ação e eficácia imunológica

Julia dos Santos Azevedo
Revista fisio&terapia.
Immunotherapy and Immune Responses
article

Vacinas de MRNA e resposta imunológica: mecanismos de ação e eficácia imunológica

Julia dos Santos Azevedo
article en

Abstract

Messenger RNA (MRNA)-based vaccines represent an unprecedented technological revolution in the history of immunology and modern biotechnology, becoming firmly established during the global health crisis triggered by the COVID-19 pandemic. Unlike traditional vaccines, which use attenuated or inactivated pathogens, this innovative platform employs synthetic nucleotide sequences encapsulated in lipid nanoparticles to instruct the host cell machinery to synthesize specific antigens endogenously. This study aimed to conduct an in-depth analysis of the molecular and cellular mechanisms of action of mRNA vaccines, as well as to evaluate their overall immunological efficacy, safety profile, and future therapeutic implications. To this end, a descriptive and analytical integrative literature review was conducted, based on a systematic search of internationally recognized scientific databases, including PubMed, SciELO, Web of Science, and Google Scholar, covering publications from 2019 to 2024. The findings synthesized from the literature demonstrate that MRNA formulations trigger a vigorous and coordinated activation of both innate and adaptive immunity. The internalization of lipid nanoparticles by dendritic cells and macrophages activates pattern recognition receptors (PRRs), inducing the secretion of essential inflammatory cytokines and chemokines. Subsequently, antigen presentation via major histocompatibility complex (MHC) molecules stimulates the activation of helper T lymphocytes (CD4⁺) and cytotoxic T lymphocytes (CD8⁺), alongside the maturation of plasma cells that produce high-affinity neutralizing antibodies and the robust generation of long-lived memory T and B lymphocytes. Documented clinical efficacy exceeded 90% against severe symptomatic disease, highlighting the platform's advantages in terms of structural flexibility and rapid adaptability to the continuous emergence of new viral variants. It is concluded that MRNA vaccines extend beyond the scope of COVID-19 prophylaxis, ushering in a new therapeutic era with potential applications in the management of malignant neoplasms, autoimmune diseases, and chronic viral infections.

Revista fisio&terapia.Vol. 30(164)
Good health and well-being
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon